Compound Summary
Polydatin
Compound Information
Polydatin
Compound Name: | Polydatin |
Compound CID: | 5281718 |
Synonyms: | Polydatin Piceid 27208-80-6 65914-17-2 Trans-Piceid More... |
Iupac Name: | (2S,3R,4S,5S,6R)-2-[3-hydroxy-5-[(E)-2-(4-hydroxyphenyl)ethenyl]phenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol |
InChI: | InChI=1S/C20H22O8/c21-10-16-17(24)18(25)19(26)20(28-16)27-15-8-12(7-14(23)9-15)2-1-11-3-5-13(22)6-4-11/h1-9,16-26H,10H2/b2-1+/t16-,17-,18+,19-,20-/m1/s1 |
InChIKey: | HSTZMXCBWJGKHG-CUYWLFDKSA-N |
Canonical Smiles: | C1=CC(=CC=C1C=CC2=CC(=CC(=C2)OC3C(C(C(C(O3)CO)O)O)O)O)O |
Isomeric Smiles: | C1=CC(=CC=C1/C=C/C2=CC(=CC(=C2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O |
Molecular Weight: | 390.4 |
Molecular Formula: | C20H22O8 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
Polydatin
Molecular Weight: | 390.4 |
Molecular Formula: | C20H22O8 |
Hydrogen Bond Donor Count: | 6 |
Hydrogen Bond Acceptor Count: | 8 |
Rotatable Bond Count: | 5 |
Heavy Atom Count: | 28 |
Complexity: | 506 |
Synonyms
Polydatin
| Polydatin | Polydatin |
|---|---|
Polydatin |
Piceid |
27208-80-6 |
65914-17-2 |
Trans-Piceid |
Polydotin Peceid |
3,4,5-Trihydroxystilbene-3-beta-monoglucoside |
3,4,5-Tsg |
(E/Z)-Polydatin |
(2S,3R,4S,5S,6R)-2-(3-Hydroxy-5-(4-hydroxystyryl)phenoxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
Polydatin (E)-isomer |
Resveratrol 3-beta-mono-D-glucoside |
Resveratrol 3-O-beta-glucopyranoside |
UNII-XM261C37CQ |
(Z/E-)-Polydatin |
(2S,3R,4S,5S,6R)-2-3-hydroxy-5-(E)-2-(4-hydroxyphenyl)ethenylphenoxy-6-(hydroxymethyl)oxane-3,4,5-triol |
MLS001424114 |
CHEBI:8198 |
XM261C37CQ |
trans-resveratrol 3-beta-glucoside |
trans-resveratrol 3-beta-D-glucoside |
3,4-5-Trihydroxystilbene-3-beta-D-glucopyranoside |
(2S,3R,4S,5S,6R)-2-(3-hydroxy-5-((E)-4-hydroxystyryl)phenoxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
trans-resveratrol 3-O-beta-D-glucoside |
3,5,4-Trihydroxystilbene 3-glucoside |
SMR000466371 |
3,4,5-trihydroxystilbene-3-beta-D-glucoside |
b-D-Glucopyranoside,3-hydroxy-5-(1E)-2-(4-hydroxyphenyl)ethenylphenyl |
C20H22O8 |
Resveratrol 3-Glucoside |
5-Tsg |
resveratrol 3-O-beta-D-glucoside |
trans-Polydatin |
MFCD00210592 |
Polydatin(Piceid) |
(E)-Polydatin |
Polydatin,(S) |
Polydatin - Piceid |
(E)-Piceid |
5-Trihydroxystilbene-3-beta-monoglucoside |
3-Hydroxy-5-(2-(4-hydroxyphenyl)ethenyl)phenyl-beta-D-glucoside |
Resveratrol 3-O-glucoside |
Resveratrol 5-O-glucoside |
SCHEMBL41411 |
trans-Resveratrol C-glucoside |
MLS000759499 |
trans-Resveratrol 3-glucoside |
CHEMBL142652 |
Resveratrol 3-beta-D-glucoside |
trans-Resveratrol 3-O-glucoside |
BDBM60919 |
CHEBI:94610 |
cid_5281718 |
DTXSID20897454 |
HMS2051A20 |
148766-36-3 |
HY-N0120 |
ZINC4098633 |
resveratrol-3-O-b-mono-D-glucoside |
b-D-Glucopyranoside, 3-hydroxy-5-2-(4-hydroxyphenyl)ethenylphenyl |
CP0092 |
LMPK13090012 |
s2390 |
AKOS015961013 |
CCG-100895 |
DB11263 |
KS-5384 |
NC00145 |
Resveratrol 3-.beta.-mono-d-glucoside |
NCGC00246971-01 |
NCGC00246971-04 |
(2S,3R,4S,5S,6R)-2-3-hydroxy-5-(E)-2-(4-hydroxyphenyl)vinylphenoxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol |
AS-13910 |
O911 |
trans-resveratrol 3-beta-d-glucopyranoside |
AB0016722 |
CS-0007830 |
AB00639953-07 |
3,4,5-Trihydroxystilbene-3-b-D-glucopyranoside |
914P172 |
A818955 |
5,4-dihydroxystilbene-3-O-beta-D-glucopyranoside |
Q-100342 |
Q3902665 |
W-203441 |
3,4,5-TRIHYDROXYSTILBENE-3-BETA-MONOGLUCOSIDE" |
3,4-5-Trihydroxystilbene-3-beta-D-glucopyranoside, 97% |
3-hydroxy-5-(E)-2-(4-hydroxyphenyl)ethenylphenyl beta-D-glucopyranoside |
beta-D-Glucopyranoside, 3-hydroxy-5-(2-(4-hydroxyphenyl)ethenyl)phenyl |
beta-D-Glucopyranoside, 3-hydroxy-5-(2-(4-hydroxyphenyl)ethenyl)phenyl-, (E)- |
(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-3-(E)-2-(4-hydroxyphenyl)ethenyl-5-oxidanyl-phenoxyoxane-3,4,5-triol |
(2S,3R,4S,5S,6R)-2-3-hydroxy-5-(E)-2-(4-hydroxyphenyl)vinylphenoxy-6-methylol-tetrahydropyran-3,4,5-triol |
.beta.-D-Glucopyranoside, 3-hydroxy-5-(1E)-2-(4-hydroxyphenyl)ethenylphenyl3,5,4-Trihydroxystilbene 3-glucoside" |
Experimental Data
Polydatin
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 1.000000000000000 | mM | 14.300000000000000 | 18.600000000000000 | 0.300000000000000 | NS | N2 | 24305800 | Inactive | ||||
| Caenorhabditis elegans | 0.010000000000000 | mM | 14.300000000000000 | 15.900000000000000 | 0.110000000000000 | S | N2 | 24305800 | Active | ||||
| Caenorhabditis elegans | 1.000000000000000 | mM | 30.070000000000000 | NS | N2 | 33683565 | Inactive | ||||||
| Caenorhabditis elegans | 0.100000000000000 | mM | 14.300000000000000 | 16.800000000000000 | 0.170000000000000 | S | N2 | 24305800 | Active | ||||
| Caenorhabditis elegans | 0.100000000000000 | mM | 17.480000000000000 | S | N2 | 33683565 | Active | ||||||
| Caenorhabditis elegans | 0.010000000000000 | mM | 11.190000000000000 | S | N2 | 33683565 | Active |
Experimental Data Visualization
Polydatin
Statistics Data
Polydatin
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 30.070000000000000 | 2 | 6 |
Statistics Data Visualization
Polydatin
